NextGen cell-based immunotherapies in cancer and other immune disorders
Azimi CS, /strong>Tang Q, Roybal KT, Bluestone JA.
Curr Opin Immunol. 2019 May 6;59:79-87. doi: 10.1016/j.coi.2019.03.007. PMID:31071513
Azimi CS, /strong>Tang Q, Roybal KT, Bluestone JA.
Curr Opin Immunol. 2019 May 6;59:79-87. doi: 10.1016/j.coi.2019.03.007. PMID:31071513